Sertralin



Indications and Reactions:

Role Indications Reactions
Primary
Product Used For Unknown Indication 40.0%
Depression 31.1%
Drug Use For Unknown Indication 6.7%
Labour Induction 4.4%
Maternal Exposure Timing Unspecified 4.4%
Prophylaxis Of Neural Tube Defect 4.4%
Gestational Diabetes 2.2%
Insomnia 2.2%
Maternal Therapy To Enhance Foetal Lung Maturity 2.2%
Sleep Disorder 2.2%
Restlessness 13.0%
Stillbirth 8.7%
Blood Thyroid Stimulating Hormone 4.3%
Completed Suicide 4.3%
Drug Ineffective 4.3%
Drug Interaction 4.3%
Erythema Multiforme 4.3%
Impaired Healing 4.3%
Lip Swelling 4.3%
Oedema Peripheral 4.3%
Overdose 4.3%
Premature Baby 4.3%
Premature Labour 4.3%
Product Quality Issue 4.3%
Prothrombin Level 4.3%
Small For Dates Baby 4.3%
Tardive Dyskinesia 4.3%
Tinnitus 4.3%
Toxicity To Various Agents 4.3%
Urinary Tract Infection 4.3%
Secondary
Product Used For Unknown Indication 34.5%
Depression 12.7%
Drug Use For Unknown Indication 10.9%
Major Depression 10.9%
Myocardial Ischaemia 9.1%
Accidental Exposure 5.5%
Restless Legs Syndrome 5.5%
Maternal Exposure Timing Unspecified 3.6%
Back Pain 1.8%
Bipolar Disorder 1.8%
Restlessness 1.8%
Sleep Disorder 1.8%
Gastric Ulcer Haemorrhage 13.3%
Completed Suicide 6.7%
Multiple Drug Overdose 6.7%
Neonatal Respiratory Distress Syndrome 6.7%
Premature Rupture Of Membranes 6.7%
Prothrombin Level 6.7%
Restlessness 6.7%
Serotonin Syndrome 6.7%
Somnolence 6.7%
Subdural Haemorrhage 6.7%
Syncope 6.7%
Thrombocytopenia 6.7%
Ventricular Tachycardia 6.7%
Weight Increased 6.7%
Concomitant
Depression 20.2%
Product Used For Unknown Indication 19.1%
Hypertension 12.2%
Prostate Cancer 8.5%
Anxiety 5.0%
Drug Use For Unknown Indication 3.4%
Insomnia 2.9%
Diabetes Mellitus 2.7%
Pulmonary Embolism 2.7%
Rheumatoid Arthritis 2.7%
Atrial Fibrillation 2.4%
Chronic Obstructive Pulmonary Disease 2.4%
Obsessive-compulsive Disorder 2.4%
Cardiovascular Disorder 2.1%
Multiple Sclerosis 2.1%
Bipolar Disorder 1.9%
Essential Hypertension 1.9%
Myocardial Ischaemia 1.9%
Pain 1.9%
Prophylaxis 1.9%
Pulmonary Embolism 11.3%
Personality Disorder 8.5%
Weight Decreased 8.5%
Depression 7.0%
Alveolitis Allergic 5.6%
Convulsion 5.6%
Placental Disorder 5.6%
Chronic Obstructive Pulmonary Disease 4.2%
Completed Suicide 4.2%
Fatigue 4.2%
Pancreatic Carcinoma 4.2%
Rash 4.2%
Sleep Disorder 4.2%
Suicide Attempt 4.2%
Weight Increased 4.2%
Cardiac Failure Congestive 2.8%
Renal Failure Acute 2.8%
Urinary Tract Infection 2.8%
Ventricular Fibrillation 2.8%
Visual Impairment 2.8%
Interacting
Product Used For Unknown Indication 26.7%
Depression 20.0%
Dyslipidaemia 13.3%
Atrial Fibrillation 6.7%
Cardiovascular Event Prophylaxis 6.7%
Deep Vein Thrombosis 6.7%
Depressed Mood 6.7%
Epilepsy 6.7%
Prophylaxis Against Gastrointestinal Ulcer 6.7%
Drug Interaction 50.0%
Hypovolaemic Shock 25.0%
International Normalised Ratio Decreased 25.0%